ALS drug pulled from market in Canada, U.S. after failing late-stage clinical trial
Amylyx Pharmaceuticals said Thursday it will withdraw its amyotrophic lateral sclerosis (ALS) drug from the market in Canada and the U.S.…
Bringing News as it Unfolds
Amylyx Pharmaceuticals said Thursday it will withdraw its amyotrophic lateral sclerosis (ALS) drug from the market in Canada and the U.S.…
Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning…
Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning…
Liberal MP Julian Leeser has accused the Australian Human Rights Commission (AHRC) of being “frozen by political paralysis” in failing…
Forbes: How AI defense tech developer Rebellion Defense is struggling to survive after failing to win a US DOD contract,…